EUVIMED · CrossrefJournal
Pharmacological Reviews
ISSN 0031-6997 · Elsevier BV
Latest articles
Kv7 channels as pharmacological targets for central nervous system diseases
The skeletal connectome: From molecular circuitry to systemic network medicine
Recombinant protein drug metabolism and pharmacokinetics
Application of human liver cell models in drug development and toxicity studies: The role of membrane transporters
Harnessing autophagy and its transcriptional regulation in tumorigenesis and neurodegeneration: Potential and existing therapeutic strategies
GPCR signaling from a primary cilium perspective
The promise of biased ligands in therapeutics
Medication adherence: An overlooked critical determinant of pharmacological effectiveness
Defining the druggability of viral macrodomains in coronaviruses and alphaviruses
PROTAC technologies for drug discovery: opportunities and challenges
International Union of Basic and Clinical Pharmacology. CXXIII. Update on endothelin pharmacology and therapeutics
Airway Mucus Dysfunction in Pulmonary Diseases: Pathophysiology, Pharmacological Targets, and Mucoactive Therapies
The Pharmacology of Gender-Affirming Hormone Therapy: From Molecular Mechanisms to Clinical Physiologic and Pathophysiologic Implications
Pharmacological Therapies for Erectile Dysfunction: A Historical and Contemporary Perspective
What macrophages can tell us about cancer and its therapy: targeting and harnessing macrophage functions
The Aging Brain and Epilepsy: Current Knowledge and Novel Therapeutic Targets
Regulation of the Mineralocorticoid Receptor in Physiology and Disease
Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions
Mitochondrial metabolism as a pharmacological target for cancer therapeutics
Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinic
Vein graft failure: Pathophysiology, detection, prevention and emerging therapeutic strategies
Are we underestimating the benefits of lipid-lowering therapies?
International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors
Erratum to “Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids” [Pharmacological Reviews 78 (2026) 100113]
Friend or foe? Glial–vascular interactions in health and neurodegenerative disease
Aryl hydrocarbon receptor pharmacology—mechanisms, ligands, and therapeutic potential
Adhesion G protein-coupled receptors
Regenerative therapeutics for chronic obstructive pulmonary disease
Emerging natural products against obesity and metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Direct target discovery and mechanistic insights
Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases
Volumes
2026 · 782025 · 832024 · 652023 · 492022 · 442021 · 512020 · 352019 · 302018 · 342017 · 272016 · 362015 · 412014 · 372013 · 462012 · 442011 · 482010 · 382009 · 332008 · 362007 · 312006 · 492005 · 352004 · 292003 · 372002 · 322001 · 422000 · 321999 · 291998 · 451997 · 331996 · 301995 · 251994 · 291993 · 201992 · 221991 · 231990 · 171989 · 221988 · 161987 · 13
EUVIMED